The study also provided insights into the predictive capacity of certain biomarkers, including CRP/FIBRINOGEN/FRIL/PIGR, for CCA development in PSC patients before clinical evidence of malignancy emerged. The gene discussed is CRP; the disease is cholangiocarcinoma.